SPRINGWORKS THERAPEUTICS, INC. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4a4749dd-43e4-49a5-9a6b-e1426f49d4bd/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-278.1M | 2024-01-01 – 2024-12-31 | evidence 0001773427-25-000010 |
| FY 2023 | $-343.0M | 2023-01-01 – 2023-12-31 | evidence 0001773427-24-000010 |
| FY 2022 | $-280.7M | 2022-01-01 – 2022-12-31 | evidence 0001773427-23-000010 |
| FY 2021 | $-173.5M | 2021-01-01 – 2021-12-31 | evidence 0001773427-22-000011 |
| FY 2020 | $-46.3M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-001708 |
| FY 2019 | $-59.2M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002563 |
| FY 2018 | $-18.5M | 2018-01-01 – 2018-12-31 | evidence 0001558370-20-002563 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
SPRINGWORKS THERAPEUTICS, INC. — all facts · Revenue · Net Income